Everest Medicines Limited (HKG:1952)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
55.75
+0.80 (1.46%)
Sep 29, 2025, 4:08 PM HKT

Everest Medicines Revenue

Everest Medicines had revenue of 446.12M CNY in the half year ending June 30, 2025, with 4,915.44% growth. This brings the company's revenue in the last twelve months to 851.28M, up 103.39% year-over-year. In the year 2024, Everest Medicines had annual revenue of 706.68M with 461.16% growth.

Revenue (ttm)
851.28M CNY
Revenue Growth
+103.39%
P/S Ratio
20.81
Revenue / Employee
1.28M CNY
Employees
665
Market Cap
19.41B HKD

Revenue Chart

* This company reports financials in CNY.

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2024706.68M580.75M461.16%
Dec 31, 2023125.93M113.14M884.46%
Dec 31, 202212.79M12.74M23,588.89%
Dec 31, 202154.00K--
Dec 31, 2020---
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition